All News

This report is the first one published since the state’s legal market began.

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

The studies highlight how changes in environment can alter cannabis during drying and curing.

In preparation for the outdoor cannabis harvest, this episode provided guidance on ensuring a successful production process.

Researchers analyzed studies from the past two decades on the impact of cannabinoids on neuropathic pain and potential benefits.

Multi-state cannabis company, Verano Holdings Corp., started a fundraising campaign with their BITS™ edibles product for Breast Cancer Awareness Month with a portion of the proceeds going to the Lynn Sage Breast Cancer Foundation.

The study surveyed cannabis patients across the country on their use and perceptions of cannabis use during cancer treatment.

Avicanna released information on a new study through MyMedi.ca which will look into the use of medical cannabis for various health ailments such as pain, anxiety, epilepsy, sleep, and depression.

A ruling is expected this week regarding the lawsuit challenging the validity of signatures collected for two medical cannabis measures.

The study found improvement in symptom relief with participants who used the suppositories, compared to the treatment-as-usual group.

A "Secret Shopper" investigation conducted by Our Delaware and the National Clinical Directors Consortium revealed alarming compliance issues in Delaware's cannabis industry. The study discovered instances of mislabeling, product contamination, and the presence of synthetic cannabinoids in cannabis products. The findings highlighted the necessity for better regulation, accurate labeling, and public health protection.

Several participants reported symptom relief and reduced reliance on pain medication.

Products containing Delta-8 THC may be leading to an increase in calls to poison control centers, according to a recent study.

A recently published white paper delves into data on market and consumer trends for pre rolls.

A recent study targeting mild to moderate anxiety disorders showed that oral CBD can be a safe, effective treatment option.

As we prepare to publish our full Back to Basics: Soil’s Crucial Role in Cannabis Cultivation interview, let’s revisit some of the tips and insights from our cultivation experts, Adam Jacques, a world-renowned cannabis geneticist and Zacariah L. Hildenbrand, a research Professor at the University of Texas at El Paso.

Voters in North Dakota will see recreational cannabis on the ballot this November.

One study analyzed nearly 100 CBD products to test the accuracy of advertised cannabinoid content.

Cannabis Science and Technology® magazine is seeking contributed manuscripts for our peer-review process and regular feature articles for upcoming 2024/2025 issues.

Researchers sought to provide community-based evidence in the co-use of opioids and cannabis among people who inject drugs.

A new study demonstrates the neuroprotective properties of the supplement N-Acetylcysteine against effects of cannabis exposure in adolescence.

This article, originally published by our sister brand LCGC International, discusses how Connecticut Agricultural Experiment Station scientists recently have been utilizing gas chromatography with flame ionization detection (GC-FID) to measure different components in cannabis hemp samples.

This month’s Healer webinar provided a deep dive into several studies on cannabis for various conditions.

This presentation provided a comprehensive overview of cannabigerol (CBG), highlighting two studies on its effects on anxiety, stress, and pain.

In honor of National CBD Day on August 8 (8/8/24), we compiled eight articles on various aspects of cannabidiol (CBD).

Read three factoids about hemp and its seeds on nutrition, history, and certification.

As reported by our sister publication, Nutritional Outlook, Fresh Hemp Foods, which is owned by Tilray Brands Inc, recently announced its acquisition of US company The Humble Seed.

The majority of comments on the scheduling of cannabis favored change, though several other aspects of cannabis policy remain to be addressed.